Related Experiment Video
Updated: May 23, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
Rosavin modulates CX3CL1 secretion and osteoblast morphology under mineralizing conditions in vitro
Piotr Wojdasiewicz1, Edyta Wróbel2, Elżbieta U Stolarczyk3
1Department of Biophysics, Physiology and Pathophysiology, Faculty of Health Sciences, Medical University of Warsaw, 5 Chałubińskiego Street, Warsaw, 02-004, Poland. piotr.wojdasiewicz@wum.edu.pl.
Background:
Rosavin, a bioactive compound derived from Rhodiola rosea, has been proposed to modulate osteoblast-associated signaling pathways. Emerging evidence highlights the role of CX3CL1 (fractalkine) in bone-immune interactions. This study aimed to investigate whether rosavin modulates CX3CL1 secretion and osteoblast morphology and confluence in human osteoblasts (HOB) in vitro, thereby providing descriptive cellular evidence relevant to CX3CL1-associated osteoblast responses under mineralizing conditions.
Methods:
Prior to biological testing, the chemical identity of rosavin was verified by high-resolution electrospray ionization quadrupole time-of-flight mass spectrometry (ESI-QTOF-MS). HOB were cultured in growth medium (DMEM-g), mineralization medium (DMEM-m), or DMEM-m supplemented with rosavin at 50 µM (R50) or 100 µM (R100). Cell morphology and confluence were assessed by phase-contrast microscopy, supported by semi-quantitative image-based estimation of cell-covered area using Fiji/ImageJ. Sirius Red staining was performed only in the DMEM-m mineralization control group and was evaluated qualitatively as a supportive assessment of extracellular matrix maturation.
Results:
Rosavin was associated with dose- and time-dependent changes in CX3CL1 secretion and morphology-related observations in HOB cultures. The 50 µM rosavin condition showed significantly increased CX3CL1 secretion at days 14 and 21 compared with DMEM-m alone and was associated with higher cell confluence and predominance of cuboidal cell morphology. In contrast, the 100 µM condition was associated with lower apparent confluence, mixed cellular morphology, and reduced CX3CL1 secretion at later time points.
Conclusions:
These observations are descriptive, preliminary, and hypothesis-generating. Rosavin was associated with concentration-dependent modulation of CX3CL1 secretion and osteoblast morphological characteristics in vitro; however, the biological significance of CX3CL1 modulation in this monoculture model remains uncertain. Further mechanistic and functional studies are required.
More Related Videos
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
Related Concept Videos
Osteoclasts in Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Bone Remodeling
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...